v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Oct. 02, 2020
Sep. 27, 2019
Statement of Cash Flows [Abstract]    
Net income $ 11,656 $ (501,813)
Adjustments to reconcile net income to net cash provided by operating activities:    
Divestiture impairment loss 0 481,000
Depreciation, amortization and other impairment charges 181,114 190,577
Stock-based compensation expense 21,642 17,005
Non-cash interest expense 4,253 5,674
Deferred income tax benefit (30,946) (18,673)
(Gain) loss on sale of property, plant and equipment 523 (140)
Pension settlement loss 0 77,390
Changes in operating assets and liabilities:    
Trade receivables, net 44,592 29,071
Inventories, net 28,556 (54,256)
Accounts payable (42,869) (98,920)
Income taxes (9,722) (39,909)
Other operating assets and liabilities (35,666) (21,257)
Net cash provided by operating activities 173,133 65,749
Cash flows from investing activities:    
Purchases of property, plant and equipment (81,583) (100,383)
Proceeds from sale of property, plant and equipment 4,929 7,474
Acquisitions, net of cash received (7,477) (3,136,777)
Net cash used in investing activities (84,131) (3,229,686)
Cash flows from financing activities:    
Proceeds from borrowings on term credit facility 0 2,725,000
Payments under term credit facility (40,000) (533,437)
Proceeds from borrowings on revolving credit facilities and other 794,678 1,780,085
Repayments of borrowings on revolving credit facilities and other (866,215) (1,136,186)
Payment of debt issuance costs (4,560) (24,402)
Proceeds from prepaid stock purchase contracts 0 377,814
Proceeds from issuance of common stock, net 2,930 4,787
Payment for noncontrolling interest share repurchase 0 93,087
Deferred consideration payments and other (12,411) (9,680)
Net cash provided by (used in) financing activities (125,578) 3,090,894
Effect of foreign exchange rates on Cash and cash equivalents (6,633) (5,216)
Decrease in Cash and cash equivalents (43,209) (78,259)
Cash and cash equivalents, beginning of period 109,632 245,019
Cash and cash equivalents, end of period $ 66,423 $ 166,760